粪菌移植在结直肠癌治疗中的研究进展及应用前景

王冉; 宋丽丽; 张一凡; 张永博; 钟延美

doi:10.3969/j.issn.1671-038X.2023.09.14

粪菌移植在结直肠癌治疗中的研究进展及应用前景

- 1.
  潍坊医学院(山东潍坊，261000)
- 2.
  潍坊市人民医院消化内科

详细信息

通讯作者: 钟延美, E-mail: ameiwf@126.com

^Δ审校者

中图分类号: R735

收稿日期: 2023-04-12

刊出日期: 2023-09-15

Research progress and application prospects of fecal microbiota transplantation in colorectal cancer treatment

- 1.
  Weifang Medical College, Weifang, Shandong, 261000, China
- 2.
  Department of Gastroenterology, Weifang People's Hospital

More Information

Corresponding author: ZHONG Yanmei, E-mail: ameiwf@126.com

Received Date: 12 April 2023

Publish Date: 15 September 2023

摘要

摘要: 结直肠癌(colorectal cancer，CRC)是消化系统常见的恶性肿瘤。近年来，人们发现肠道菌群改变通过各种复杂的机制影响CRC的发生、发展。粪菌移植(fecal microbiota transplantation，FMT)作为一种重建肠道菌群的新技术，通过将健康供体的肠道菌群移植到患者肠道中，可以达到重新调节肠道菌群平衡的目的。本文对肠道菌群影响CRC的机制以及FMT在CRC治疗中的研究进展及应用前景进行综述，特别是对FMT在减轻CRC治疗引起的不良反应、影响CRC患者抗癌治疗的效果，以及CRC预防中的潜力等方面进行总结。
- 粪菌移植 /
- 肠道菌群 /
- 结直肠癌 /
- 治疗
Abstract: Colorectal cancer(CRC) is a common malignant tumor of the gastrointestinal system, and recently, it has been found that gut microbiota changes affect the development of CRC through various complex mechanisms. Fecal microbiota transplantation(FMT) is a new technique to rebalance the gut microbiota by transplanting gut microbiota from a healthy donor into the patient's intestine. In this paper, we review the mechanism of gut microbiota affecting CRC and the research progress and application prospects of FMT in CRC treatment, especially the potential of FMT in reducing the adverse effects caused by CRC treatment, influencing the effect of anti-cancer treatment in CRC patients, and the potential of CRC prevention.
- fecal microbiota transplantation /
- gut microbiota /
- colorectal cancer /
- treatment

HTML全文

参考文献(51)

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
[2]	许广慈, 杨如意. 大肠癌患者癌因性疲乏的中西医治疗进展[J]. 中国中西医结合消化杂志, 2022, 30(9): 673-678. https://zxyxh.whuhzzs.com/article/doi/10.3969/j.issn.1671-038X.2022.09.12
[3]	Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer[J]. Lancet, 2019, 394(10207): 1467-1480. doi: 10.1016/S0140-6736(19)32319-0
[4]	Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(11): 690-704. doi: 10.1038/s41575-019-0209-8
[5]	Dupont HL, Jiang ZD, Dupont AW, et al. The intestinal microbiome in human health and disease[J]. Trans Am Clin Climatol Assoc, 2020, 131: 178-197.
[6]	Xue LJ, Yang XZ, Tong Q, et al. Fecal microbiota transplantation therapy for Parkinson's disease: a preliminary study[J]. Medicine(Baltimore), 2020, 99(35): e22035.
[7]	Thursby E, Juge N. Introduction to the human gut microbiota[J]. Biochem J, 2017, 474(11): 1823-1836. doi: 10.1042/BCJ20160510
[8]	Feng QQ, Chen WD, Wang YD. Gut microbiota: an integral moderator in health and disease[J]. Front Microbiol, 2018, 9: 151. doi: 10.3389/fmicb.2018.00151
[9]	章梦琪, 李金骁, 尚罗锐, 等. 基于肠道菌群-肠-脑轴探讨膳食营养对消化心身疾病影响的研究进展[J]. 中国中西医结合消化杂志, 2023, 31(1): 29-36. https://zxyxh.whuhzzs.com/article/doi/10.3969/j.issn.1671-038X.2023.01.06
[10]	Laukens D, Brinkman BM, Raes J, et al. Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design[J]. FEMS Microbiol Rev, 2016, 40(1): 117-132. doi: 10.1093/femsre/fuv036
[11]	章菲菲, 毛凌燕, 蔡娟, 等. 结直肠癌患者的肠道菌群变化情况分析[J]. 中国社区医师, 2022, 38(9): 90-92. https://www.cnki.com.cn/Article/CJFDTOTAL-XCYS202209030.htm
[12]	Saus E, Iraola-Guzman S, Willis JR, et al. Microbiome and colorectal cancer: roles in carcinogenesis and clinical potential[J]. Mol Aspects Med, 2019, 69: 93-106. doi: 10.1016/j.mam.2019.05.001
[13]	Cheng YW, Ling ZX, Li LJ. The intestinal microbiota and colorectal cancer[J]. Front Immunol, 2020, 11: 615056. doi: 10.3389/fimmu.2020.615056
[14]	Rubinstein MR, Wang XW, Liu W, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin[J]. Cell Host Microbe, 2013, 14(2): 195-206. doi: 10.1016/j.chom.2013.07.012
[15]	Long XH, Wong CC, Tong L, et al. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity[J]. Nat Microbiol, 2019, 4(12): 2319-2330. doi: 10.1038/s41564-019-0541-3
[16]	Li JC, Zhu YZ, Yang L, et al. Effect of gut microbiota in the colorectal cancer and potential target therapy[J]. Discov Oncol, 2022, 13(1): 51. doi: 10.1007/s12672-022-00517-x
[17]	Cougnoux A, Dalmasso G, Martinez R, et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype[J]. Gut, 2014, 63(12): 1932-1942. doi: 10.1136/gutjnl-2013-305257
[18]	Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer[J]. Nat Immunol, 2016, 17(3): 230-240. doi: 10.1038/ni.3384
[19]	Martin OCB, Bergonzini A, D'Amico F, et al. Infection with genotoxin-producing Salmonella enterica synergises with loss of the tumour suppressor APC in promoting genomic instability via the PI3K pathway in colonic epithelial cells[J]. Cell Microbiol, 2019, 21(12): e13099.
[20]	Xu H, Cao CX, Ren YQ, et al. Antitumor effects of fecal microbiota transplantation: implications for microbiome modulation in cancer treatment[J]. Front Immunol, 2022, 13: 949490. doi: 10.3389/fimmu.2022.949490
[21]	肖岑昕, 黄恒青, 柯晓, 等. 粪菌移植在功能性便秘中的应用进展[J]. 中国中西医结合消化杂志, 2022, 30(3): 239-243. https://zxyxh.whuhzzs.com/article/doi/10.3969/j.issn.1671-038X.2022.03.13
[22]	Biazzo M, Deidda G. Fecal microbiota transplantation as new therapeutic avenue for human diseases[J]. J Clin Med, 2022, 11(14): 4119. doi: 10.3390/jcm11144119
[23]	孙中美, 李军祥, 胡立明, 等. 葛洪《肘后备急方》应用粪便治疗疾病探析[J]. 中医学报, 2019, 34(5): 916-919. doi: 10.16368/j.issn.1674-8999.2019.05.218
[24]	徐浩杰, 王璐, 陈蓓迪, 等. 粪菌移植: 中西医诊疗思维的碰撞[J]. 中国医学科学院学报, 2022, 44(3): 472-477. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYKX202203018.htm
[25]	句英娇, 王小通, 王隐瑜, 等. 宏基因组及培养组学技术在粪菌移植中的应用[J]. 生物工程学报, 2022, 38(10): 3594-3605. doi: 10.13345/j.cjb.220573
[26]	Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis[J]. Surgery, 1958, 44(5): 854-859.
[27]	Hvas CL, Dahl Jorgensen SM, Jorgensen SP, et al. Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection[J]. Gastroenterology, 2019, 156(5): 1324-1332.e3. doi: 10.1053/j.gastro.2018.12.019
[28]	Ooijevaar RE, Terveer EM, Verspaget HW, et al. Clinical application and potential of fecal microbiota transplantation[J]. Annu Rev Med, 2019, 70: 335-351. doi: 10.1146/annurev-med-111717-122956
[29]	Villeger R, Lopes A, Carrier G, et al. Intestinal microbiota: a novel target to improve anti-tumor treatment?[J]. Int J Mol Sci, 2019, 20(18): 4584. doi: 10.3390/ijms20184584
[30]	朱德祥, 任黎, 许剑民. 中国《结直肠癌肝转移诊断和综合治疗指南》(V2013)解析[J]. 中华胃肠外科杂志, 2014, 17(6): 525-529. doi: 10.3760/cma.j.issn.1671-0274.2014.06.002
[31]	桑温昌, 李兆德, 杨林, 等. 粪菌移植治疗直肠癌根治术后肠道功能紊乱43例疗效观察[J]. 中国肛肠病杂志, 2022, 42(6): 4-7. https://www.cnki.com.cn/Article/CJFDTOTAL-GCBZ202206002.htm
[32]	刘琦, 黄懿华, 温昕. 肠道微生态移植对胃肠道术后菌群失调患者的临床观察[J]. 中国处方药, 2020, 18(1): 148-149. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCF202001086.htm
[33]	Chang CW, Lee HC, Li LH, et al. Fecal microbiota transplantation prevents intestinal injury, upregulation of toll-like receptors, and 5-fluorouracil/oxaliplatin-induced toxicity in colorectal cancer[J]. Int J Mol Sci, 2020, 21(2): 386.
[34]	Le Bastard Q, Ward T, Sidiropoulos D, et al. Fecal microbiota transplantation reverses antibiotic and chemotherapy-induced gut dysbiosis in mice[J]. Sci Rep, 2018, 8(1): 6219.
[35]	桂冠, 易健, 张善金, 等. 粪菌移植疗法治疗晚期结直肠癌FOLFIRI化疗方案相关难治性腹泻的效果观察[J]. 中国医学创新, 2021, 18(30): 10-14. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCX202130005.htm
[36]	Cui M, Xiao HW, Li Y, et al. Faecal microbiota transplantation protects against radiation-induced toxicity[J]. EMBO Mol Med, 2017, 9(4): 448-461.
[37]	刘金金, 梅彩玲, 何燕华, 等. 粪菌移植治疗放射性肠炎20例疗效观察[J]. 药品评价, 2021, 18(15): 927-929. https://www.cnki.com.cn/Article/CJFDTOTAL-YPPJ202115009.htm
[38]	Ding X, Li QQ, Li P, et al. Fecal microbiota transplantation: a promising treatment for radiation enteritis?[J]. Radiother Oncol, 2020, 143: 12-18.
[39]	李宁, 田宏亮, 马春联, 等. 菌群移植治疗肠道疾病406例疗效分析[J]. 中华胃肠外科杂志, 2017, 20(1): 40-46.
[40]	Huang JY, Zheng X, Kang WY, et al. Metagenomic and metabolomic analyses reveal synergistic effects of fecal microbiota transplantation and anti-PD-1 therapy on treating colorectal cancer[J]. Front Immunol, 2022, 13: 874922.
[41]	Wang Y, Li H. Gut microbiota modulation: a tool for the management of colorectal cancer[J]. J Transl Med, 2022, 20(1): 178.
[42]	Kazmierczak-Siedlecka K, Daca A, Fic M, et al. Therapeutic methods of gut microbiota modification in colorectal cancer management-fecal microbiota transplantation, prebiotics, probiotics, and synbiotics[J]. Gut Microbes, 2020, 11(6): 1518-1530.
[43]	Wang YH, Wiesnoski DH, Helmink BA, et al. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis[J]. Nat Med, 2018, 24(12): 1804-1808.
[44]	John Kenneth M, Tsai HC, Fang CY, et al. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer[J]. J Adv Res, 2022: S2090-S1232(22)00295-8.
[45]	Wang ZT, Hua WJ, Li C, et al. Protective role of fecal microbiota transplantation on colitis and colitis-associated colon cancer in mice is associated with treg cells[J]. Front Microbiol, 2019, 10: 2498.
[46]	吴成成, 黄海鹏, 罗文兵. 基于IL-6/STAT3信号通路探讨粪菌移植干预湿热蕴结型肠癌小鼠的作用机制[J]. 药品评价, 2021, 18(12): 722-724. https://www.cnki.com.cn/Article/CJFDTOTAL-YPPJ202112006.htm
[47]	Rosshart SP, Vassallo BG, Angeletti D, et al. Wild mouse gut microbiota promotes host fitness and improves disease resistance[J]. Cell, 2017, 171(5): 1015-1028.e13.
[48]	DeFilipp Z, Bloom PP, Torres Soto M, et al. Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant[J]. N Engl J Med, 2019, 381(21): 2043-2050.
[49]	Carlson PE Jr. Regulatory considerations for fecal microbiota transplantation products[J]. Cell Host Microbe, 2020, 27(2): 173-175.
[50]	Gupta S, Mullish BH, Allegretti JR. Fecal microbiota transplantation: the evolving risk landscape[J]. Am J Gastroenterol, 2021, 116(4): 647-656.
[51]	Halaweish HF, Boatman S, Staley C. Encapsulated fecal microbiota transplantation: development, efficacy, and clinical application[J]. Front Cell Infect Microbiol, 2022, 12: 826114.